0000893949false00008939492024-11-292024-11-29

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 29, 2024

 

 

 

 

img260294877_0.jpg

 

Pediatrix Medical Group, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Florida

001-12111

26-3667538

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

1301 Concord Terrace

 

Sunrise, Florida

 

33323

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 954 384-0175

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, par value $.01 per share

 

MD

 

The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On December 5, 2024, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), and Dr. Curtis B. Pickert, the current Executive Vice President, Chief Physician Executive and former Chief Operating Officer of the Company, announced that Dr. Pickert would transition from his role at the Company, effective as of January 31, 2025. Dr. Pickert was notified by the Company of his transition on November 29, 2024.

Dr. Pickert’s transition from his role as Executive Vice President and Chief Physician Executive is a termination without “Cause” pursuant to that certain Second Amended and Restated Employment Agreement, dated April 26, 2023, by and between Dr. Pickert and a wholly-owned subsidiary of the Company, and Dr. Pickert will receive the benefits thereunder following the execution of a general release of claims in favor of the Company.

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Pediatrix Medical Group, Inc.

 

 

 

 

Date:

December 5, 2024

By:

/s/ Kasandra H. Rossi

 

 

 

Kasandra H. Rossi
Chief Financial Officer

 

v3.24.3
Document And Entity Information
Nov. 29, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 29, 2024
Entity Registrant Name Pediatrix Medical Group, Inc.
Entity Central Index Key 0000893949
Entity Emerging Growth Company false
Entity File Number 001-12111
Entity Incorporation, State or Country Code FL
Entity Tax Identification Number 26-3667538
Entity Address, Address Line One 1301 Concord Terrace
Entity Address, City or Town Sunrise
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33323
City Area Code 954
Local Phone Number 384-0175
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $.01 per share
Trading Symbol MD
Security Exchange Name NYSE
Pediatrix Medical (NYSE:MD)
Historical Stock Chart
Von Nov 2024 bis Dez 2024 Click Here for more Pediatrix Medical Charts.
Pediatrix Medical (NYSE:MD)
Historical Stock Chart
Von Dez 2023 bis Dez 2024 Click Here for more Pediatrix Medical Charts.